Staphylococcal Sepsis: Treatment


Staphylococcus aureus is a virulent pathogen that causes both asymptomatic colonization and infection. S. aureus is the most common cause of skin and soft tissue infections. In hospitals, S. aureus is the most common cause of surgical site infection, and a common cause of bacteraemia. Epidemic strains of Staphylococcus aureus (and especially methicillinā€resistant S. aureus, MRSA) may spread in hospitals via dust and air, staff hands and contaminated medical devices and equipment.

Keywords: staphylococcus aureus; MRSA; bacteraemia


Acar JR, Courvalin P and Chabbert YA (1970) Methicillin‐resistant staphylococcemia: bacteriological failure of treatment with cephalosporins. Antimicrobial Agents and Chemotherapy 10: 280–285.

Caputo GM, Archer GL, Calderwood SB, DiNubile MJ and Karchmer AW (1987) Native valve endocarditis due to coagulase‐negative staphylococci. Clinical and microbiologic features. American Journal of Medicine 83: 619–625.

Centers for Disease Prevention and Control (1997) Staphylococcus aureus with reduced susceptibility to vancomycin – United States. MMWR 46: 765–766.

Centers for Disease Prevention and Control (2002) Vancomycin‐resistant Staphylococcus aureus– Pennsylvania. MMWR. Oct 11th 2002 p. 902.

Cercenado E, Garcia‐Leoni ME, Diaz MD et al. (1996) Emergence of teicoplanin‐resistant coagulase‐negative staphylococci. Journal of Clinical Microbiology 34: 1765–1781.

Chambers HF (1997) Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clinical Microbiology Reviews 10: 781–791.

Combined Working Party (1998) Revised guidelines for the control of methicillin‐resistant Staphylococcus aureus infection in hospitals. Journal of Hospital Infection 39: 253–290.

Cosgrove S, Sakoulas G, Peremcevitch EN et al. (2003) Comparison of mortality associated with methicillin‐resistant and methicillin‐susceptible Staphylococcus aureusbacteraemia: a meta‐analysis. Clinical Infectious Diseases 36: 53–59.

Daum TE, Schaberg DR, Terpenning MS, Sottile WA and Kauffman CA (1990) Increasing resistance of Staphylococcus aureus to ciprofloxacin. Antimicrobial Agents and Chemotherapy 34: 1862–1863.

de Gorgolas M, Aviles P, Verdejo C and Fernandez Guerrero ML (1995) Treatment of experimental endocarditis due to methicillin‐susceptible or methicillin‐resistant Staphylococcus aureus with trimethoprim‐sulfamethoxazole and antibiotics that inhibit cell wall synthesis. Antimicrobial Agents and Chemotherapy 39: 953–957.

Engemann JJ, Carmeli Y, Cosgrove S et al. (2003) Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clinical Infectious Diseases 36: 592–598.

Enright MC, Robinson DA, Randle G et al. (2002) The evolutionary history of methicillin‐resistant Staphylococcus aureus (MRSA). Proceedings of the National Academy of Sciences of the USA 99: 7687–7692.

French G (2003) Safety and tolerability of linezolid. Journal of Antimicrobial Chemotherapy 51(suppl. ii): 45–53.

Gemmell CG, Edwards DI, Fraise AP et al. for the BSAC/HIS/ICNA MRSA Working Party. Guidelines for the prophylaxis and treatment of meticillin (methicillin)‐resistant Staphylococcus aureus (MRSA) infections in the United Kingdom. Draft for consultation 1‐3‐05.

Hackbarth CJ and Chambers HF (1989) Methicillin‐resistant staphylococci: genetics and mechanisms of resistance. Antimicrobial Agents and Chemotherapy 33: 991–994.

Hiramatsu K, Hanaki H, Ino T et al. (1997) Methicillin‐resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. Journal of Antimicrobial Chemotherapy 40: 135–136.

Hospital Infection Control Practices Advisory Committee (1995) Recommendations for preventing the spread of vancomycin‐resistance. Infection Control and Hospital Epidemiology 16: 105–113. [Erratum: Infection Control and Hospital Epidemiology 16: 498.].

Johnson AP and Livermore DM (1999) Quinupristin/dalfopristin, a new addition to the antimicrobial arsenal. Lancet 354: 2012–2013.

Kaplan SL, Mason EO Jr. and Feigin RD (1982) Clindamycin versus nafcillin or methicillin in the treatment of Staphylococcus aureus osteomyelitis in children. Southern Medical Journal 75: 138–142.

Karchmer AW (1988) Antibiotic therapy of nonenterococcal streptococcal and staphylococcal endocarditis: current regimes and some future considerations. Journal of Antimicrobial Chemotherapy 21(suppl. C): 91.

Kirby WMM, Perry DM and Bauer AW (1960) Treatment of staphylococcal septicemia with vancomycin. Report of thirty‐three cases. New England Journal of Medicine 262: 49.

Korzeniowski O and Sande MA (1982) The National Collaborative Endocarditis Study Group. Combination antimicrobial therapy for Staphylococcus aureus endocarditis for patients addicted to parental drugs and in nonaddicts. Annals of Internal Medicine 97: 496.

Leclerq R and Courvalin P (1997) Resistance to glycopeptides in enterococci. Clinical Infectious Diseases 24: 545–556.

Livermore DM (2003) Linezolid in vitro: mechanism and antibacterial spectrum. Journal of Antimicrobial Chemotherapy 51(Suppl. ii): 9–16.

Markowitz N, Quinn EL and Saravolatz LD (1992) Trimethoprim‐sulphamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Annals of Internal Medicine 117: 390–398.

Massanari RM and Donta ST (1978) The efficacy of rifampicin as adjunctive therapy in selected cases of staphylococcal endocarditis. Chest 73: 375–377.

May J, Shannon K, King A and French GL (1998) Glycopeptide tolerance in Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 42: 189–197.

Nichols RL, Graham DR, Barriere SL et al. (1999) Treatment of hospitalized patients with complicated gram‐positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Journal of Antimicrobial Chemotherapy 44: 263–273.

Noble WC, Virani Z and Cree RGA (1992) Co‐transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiology Letters 93: 195–198.

Patrick CC, Kaplan SL, Baker CJ, Parisi JT and Mason EO Jr (1989) Persistent bacteremia due to coagulase‐negative staphylococci in low birth weight neonates. Pediatrics 84: 977–985.

Protier H (1990) A multicentre, open, clinical trial of a new intravenous formulation of fusidic acid in severe staphylococcal infection. Journal of Antimicrobial Chemotherapy 25(suppl. B): 39–44.

Shanson DC (1981) Antibiotic resistance in Staphylococcus aureus. Journal of Hospital Infection 2: 11–36.

Shanson DC (1990) Clinical relevance of resistance to fusidic acid in Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 25(suppl. B): 15–21.

Speller DCE, Johnson AP, James D et al. (1997) Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989‐95. Lancet 350: 323–325.

Tamer MA and Bray JD (1986) Trimethoprim‐sulfamethoxazole treatment of multiantibiotic‐resistant staphylococcal endocarditis and meningitis. Clinical Pediatrics 21: 125–126.

Teare L, Cookson B, French G et al. (1999) Hand washing. A modest measure with big effects. British Medical Journal 318: 686.

Van der Auwera P, Klastersky J, Thys JP et al. (1985) Double‐blind, placebo‐controlled study of oxacillin combined with rifampicin in the treatment of staphylococcal infections. Antimicrobial Agents and Chemotherapy 28: 467.

Wilcox MH (2003) Efficacy of linezolid versus comparator therapies in Gram‐positive infections. Journal of Antimicrobial Chemotherapy 51(Suppl. ii): 27–35.

Wilson AP, Gruneberg RN, Treasure T and Sturridge MF (1988) Staphylococcus epidermidis as a cause of postoperative wound infection after cardiac surgery: assessment of pathogenicity by a wound‐scoring method. British Journal of Surgery 75: 168–170.

Wilson APR and Gruneberg RN (1997) Teicoplanin: The First Decade. London: The Medicine Group.

Further Reading

Cohen J (1997) Septicaemia. In: O'Grady F, Lambert HP, Finch RG and Greenwood D (eds) Antibiotic and Chemotherapy, 7th ed., pp. 578–593. New York: Churchill Livingstone.

Elliott TSJ (1988) Intravascular‐device infections. Journal of Medical Microbiology 27: 167–167.

Kucers A, Hoy JF, Lindsay GM and Crowe SM (1997) The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal and Antiviral Drugs, 5th edn. Hodder Arnold Publications, 1997.

Michel M and Gutmann L (1997) Methicillin‐resistant Staphylococcus aureus and vancomycin‐resistant enterococci: therapeutic realities and possibilities. Lancet 349: 1901–1906.

Mulligan ME, Murray‐Leisure KA, Ribner BS et al. (1993) Methicillin‐resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. American Journal of Medicine 94: 313–328.

Rupp ME and Archer GL (1994) Coagulase‐negative staphylococci: pathogens associated with medical progress. Clinical Infectious Diseases 19: 231–243.

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
French, G L(Jan 2006) Staphylococcal Sepsis: Treatment. In: eLS. John Wiley & Sons Ltd, Chichester. [doi: 10.1038/npg.els.0001996]